title: Is 18F-FDG PET a 'potentially hazardous' or an effective tool in evaluating patients with large-vessel vasculitis?
authors: G
authors: G
authors: Treglia
authors: A
authors: A
authors: Versari
authors: L
authors: L
authors: Giovanella
authors: N
authors: N
authors: Pipitone
authors: C
authors: C
authors: Salvarani
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D006801:Humans; D056647:Systemic Vasculitis / Q000188:drug therapy*
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D003520:Cyclophosphamide